Clinical trials: Pseudotumor
Haemophilic Pseudotumour
HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor
This is a single arm, phase 4, prospective, open-label, United States single-center study to assess the hemostatic efficacy and safety of Hemlibra (emicizumab) for hemostatic control of hemophilia A patients (baseline FVIII level…
- Trial name
- NCT03921294
- Testing
- Emicizumab
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Indiana Hemophilia &Thrombosis Center, Inc.